sb 202190 has been researched along with Bladder Cancer in 2 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Felipe, KB | 1 |
| Benites, J | 1 |
| Glorieux, C | 1 |
| Sid, B | 1 |
| Valenzuela, M | 1 |
| Kviecinski, MR | 1 |
| Pedrosa, RC | 1 |
| Valderrama, JA | 1 |
| Levêque, P | 1 |
| Gallez, B | 1 |
| Verrax, J | 1 |
| Buc Calderon, P | 1 |
| Shan, Y | 1 |
| Wu, K | 1 |
| Wang, W | 1 |
| Wang, S | 1 |
| Lin, N | 1 |
| Zhao, R | 1 |
| Cassidy, A | 1 |
| Bao, Y | 1 |
2 other studies available for sb 202190 and Bladder Cancer
| Article | Year |
|---|---|
Antiproliferative effects of phenylaminonaphthoquinones are increased by ascorbate and associated with the appearance of a senescent phenotype in human bladder cancer cells.
Topics: Aminophenols; Aniline Compounds; Antineoplastic Agents; Ascorbic Acid; Caspase 3; Cell Cycle Checkpo | 2013 |
Sulforaphane down-regulates COX-2 expression by activating p38 and inhibiting NF-kappaB-DNA-binding activity in human bladder T24 cells.
Topics: Anticarcinogenic Agents; Cell Line, Tumor; Cyclooxygenase 2; Dose-Response Relationship, Drug; Down- | 2009 |